Afroway Pharma — Kit Exporter Profile
Indian Pharmaceutical Exporter · #11 for Kit · $1.9M export value · DGFT Verified
Afroway Pharma is the #11 Indian exporter of Kit with $1.9M in export value and 37 verified shipments. Afroway Pharma holds a 0.4% market share in Kit exports across 4 countries. The company exports 4 pharmaceutical products worth $27.0M across 3 therapeutic categories.
Afroway Pharma — Kit Export Profile: Buyers & Destinations
Where Does Afroway Pharma Export Kit?
| Country | Value | Shipments | Share |
|---|---|---|---|
| KENYA | $445.7K | 32 | 93.5% |
| SOUTH SUDAN | $13.8K | 3 | 2.9% |
| SIERRA LEONE | $12.9K | 1 | 2.7% |
| SUDAN | $4.3K | 1 | 0.9% |
Afroway Pharma exports Kit to 4 countries. The largest destination is KENYA accounting for 93.5% of Afroway Pharma's Kit shipments, followed by SOUTH SUDAN (2.9%) and SIERRA LEONE (2.7%). These destinations reflect Afroway Pharma's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Kit from Afroway Pharma?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| THE MANAGER, | SOUTH SUDAN | $346.2K | 19 |
| EURO PHARMA LTD. | KENYA | $90.6K | 8 |
| THE MANAGER | SOUTH SUDAN | $26.6K | 8 |
| ADERDE PHARMACUTICALS | KENYA | $9.0K | 1 |
| THE MANAGER SHOP | SUDAN | $4.3K | 1 |
Afroway Pharma supplies Kit to 5 buyers globally. The largest buyer is THE MANAGER, (SOUTH SUDAN), followed by EURO PHARMA LTD. (KENYA) and THE MANAGER (SOUTH SUDAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Kit Export Value and How Much Does Afroway Pharma Contribute?
India exported $57.8M worth of Kit through 15,000 shipments from 1048 suppliers to 191 countries, serving 3,293 buyers globally. Afroway Pharma contributes $1.9M to this total, accounting for 0.4% of India's Kit exports. Afroway Pharma ships Kit to 4 countries through 5 buyers.
What Is the Average Shipment Value for Afroway Pharma's Kit Exports?
Afroway Pharma's average Kit shipment value is $50.0K per consignment, based on 37 shipments totaling $1.9M. The largest destination is KENYA (93.5% of Afroway Pharma's Kit exports).
How Does Afroway Pharma Compare to Other Indian Kit Exporters?
Afroway Pharma ranks #11 among 1048 Indian Kit exporters with a 0.4% market share. The top 3 exporters are SANDOZ PRIVATE LIMITED ($7.8M), MERIL DIAGNOSTICS PRIVATE LIMITED ($5.6M), MICRO LABS LIMITED ($5.5M). Afroway Pharma processed 37 shipments to 4 destination countries.
What Kit Formulations Does Afroway Pharma Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PYLOCARE KITS LANSOPRAZOLE CAPSULES & CL | $219.6K | 6 |
| PYLOCARE KIT TABS LANSOPRAZOLE CAPSULES | $41.5K | 4 |
| ESOCARE KIT H. PYLORI KIT BATCH NO.NT230 | $30.8K | 1 |
| ESOCARE KIT?TAB?ESOCARE H. PYLORI KIT,BATCH NO.501,MFG.DATE.JAN-25,EXP.DATE.DEC-27(19596PCS) | $29.0K | 1 |
| ESOCARE KIT EMBOSSSED BATCH NO.NT22130A, | $19.0K | 1 |
| PYLOCARE KIT H. PYLORI KIT BATCH NO.401MFG DT:JAN-24 EXP DT:DEC-26 (9000 NOS) | $15.9K | 1 |
| PYLOCARE KIT H. PYLORI KIT BATCH NO.402MFG DT:FEB-24 EXP DT:JAN-27 (9000 NOS) | $15.9K | 1 |
| PYLOCARE KIT BATCH NO.ET25001 MFG DT:JAN-25 EXP DT:DEC-27 (8800 PCS) | $14.5K | 1 |
| PYLOCARE KIT,H.PYLORI.KIT ,BATCH NO.ET25001,MFG.DT.JAN-25,EXP.DT.DEC-27(6000PCS) | $12.9K | 1 |
| ESOCARE-KIT TAB H. PYLORI KIT BATCH NO.356 MANUFACTURING DT:SEP-23 EXP DT:AUG-26 6440 NOS | $9.8K | 1 |
Afroway Pharma exports 27 distinct Kit formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PYLOCARE KITS LANSOPRAZOLE CAPSULES & CL with 6 shipments worth $219.6K.
How Does Afroway Pharma Compare to Nearest Kit Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | BABA AGENCIES | $2.5M | 49 | 1 | $50.0K |
| 15 | ALKEM LABORATORIES LIMITED | $2.1M | 67 | 2 | $31.0K |
| 11 | AFROWAY PHARMA ★ | $1.9M | 37 | 4 | $50.0K |
| 4 | MACLEODS PHARMACEUTICALS LTD | $1.8M | 36 | 7 | $50.0K |
Afroway Pharma ranks #11 among 1048 Indian Kit exporters. Average shipment value of $50.0K compared to the market average of $55.1K. The closest competitors by value are BABA AGENCIES and ALKEM LABORATORIES LIMITED.
Which Indian Ports Ship Kit Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 2,763 | 18.4% |
| SAHAR AIR | 2,534 | 16.9% |
| DELHI AIR CARGO ACC (INDEL4) | 1,051 | 7.0% |
| DELHI AIR | 983 | 6.6% |
| NHAVA SHEVA SEA (INNSA1) | 901 | 6.0% |
| Bombay Air | 541 | 3.6% |
| JNPT/ NHAVA SHEVA SEA | 433 | 2.9% |
| CHENNAI AIR CARGO ACC (INMAA4) | 405 | 2.7% |
Geopolitical & Trade Policy Impact on Afroway Pharma's Kit Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Afroway Pharma. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, causing increased shipping costs and extended transit times (pharmaceuticalcommerce.com). These disruptions can affect the timely delivery of pharmaceuticals, particularly to markets in West Asia and North Africa, regions that accounted for $1.75 billion of India's pharma exports in FY25.
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to expand their footprint in the US market, which remains the largest destination for Indian pharma exports, accounting for 34% of the total (economictimes.indiatimes.com). Afroway Pharma can leverage this opportunity by enhancing its compliance with US regulatory standards and strengthening its supply chain resilience.
The recent India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, aims to eliminate or reduce tariffs on goods traded between India and EFTA countries (en.wikipedia.org). This agreement could facilitate easier access for Afroway Pharma's products into European markets, provided the company aligns with the stringent regulatory requirements of these regions.
Afroway Pharma — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. India's pharmaceutical sector maintains high compliance standards, with numerous US FDA-approved facilities and WHO-GMP-approved plants (manufacturing.economictimes.indiatimes.com). Afroway Pharma's adherence to these standards is crucial for maintaining and expanding its export markets.
The evolving regulatory landscape, including the EU's falsified medicines directive, necessitates continuous quality assurance and compliance efforts. For Afroway Pharma, staying abreast of these changes and implementing necessary quality control measures will be essential to sustain its export growth and market credibility.
About Afroway Pharma
Afroway Pharma exports 4 products worth $27.0M. Beyond Kit, top products include Artesunate, Artemether, Lansoprazole. View the complete Afroway Pharma profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Kit — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Kit shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Afroway Pharma matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 37 individual customs records matching Afroway Pharma exporting Kit, covering 27 formulations to 4 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 191+ countries, 3,293+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Kit Export Data from Afroway Pharma
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Afroway Pharma's Kit exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Afroway Pharma
Full Company Profile →
4 products · $27.0M total trade · 3 categories
Kit Stats
Company Overview
Top Products by Afroway Pharma
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Afroway Pharma.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Kit. For current shipment-level data, contact TransData Nexus.